Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Bongertz

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature|August 27, 2005
Extra controls will waste yet more research timeVera Bongertz
Memorias Do Instituto Oswaldo Cruz|May 4, 2005
Report of the Fifth Brazilian Symposium on HIV/AIDS Research. Rio de Janeiro, RJ, Brazil. November 23-26, 2003Vera Bongertz, Dumith Chequer Bou-Habib, Luiz Roberto R Castello-Branco, et al.
Memorias Do Instituto Oswaldo Cruz|May 4, 2005
Is human immunodeficiency virus/acquired immunodeficiency syndrome decreasing among Brazilian injection drug users? Recent findings and how to interpret themFrancisco I Bastos, Vera Bongertz, Sylvia Lopes Teixeira, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-onesNúbia Boechat, W Bruce Kover, Vera Bongertz, et al.
Substance Use & Misuse|February 11, 2005
The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, BrazilMariana A Hacker, Samuel R Friedman, Paulo Roberto Telles, et al.
Memorias Do Instituto Oswaldo Cruz|December 7, 2007
Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatmentVera Bongertz, E Priscilla Ouverney, Saada Chequer Fernandez, et al.
Memorias Do Instituto Oswaldo Cruz|May 24, 2003
Anti-human immunodeficiency virus-1 antibody titers in injection drug users compared to sexually infected individualsVera Bongertz, Elaine Priscilla Ouverney, Sylvia L M Teixeira, et al.
AIDS Research and Human Retroviruses|November 14, 2012
Short communication: neutralizing antibodies in HIV-1-infected Brazilian individualsDalziza Victalina Almeida, Mariza Gonçalvez Morgado, Fernanda Heloise Côrtes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 7, 2004
HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversitySylvia Lopes Maia Teixeira, Francisco Inácio Bastos, Paulo Roberto Telles, et al.
Journal of Medical Virology|August 22, 2009
Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1Gonzalo Bello, Carlos A Velasco-de-Castro, Vera Bongertz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature|August 27, 2005
Extra controls will waste yet more research timeVera Bongertz
Memorias Do Instituto Oswaldo Cruz|May 4, 2005
Report of the Fifth Brazilian Symposium on HIV/AIDS Research. Rio de Janeiro, RJ, Brazil. November 23-26, 2003Vera Bongertz, Dumith Chequer Bou-Habib, Luiz Roberto R Castello-Branco, et al.
Memorias Do Instituto Oswaldo Cruz|May 4, 2005
Is human immunodeficiency virus/acquired immunodeficiency syndrome decreasing among Brazilian injection drug users? Recent findings and how to interpret themFrancisco I Bastos, Vera Bongertz, Sylvia Lopes Teixeira, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-onesNúbia Boechat, W Bruce Kover, Vera Bongertz, et al.
Substance Use & Misuse|February 11, 2005
The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, BrazilMariana A Hacker, Samuel R Friedman, Paulo Roberto Telles, et al.
Memorias Do Instituto Oswaldo Cruz|December 7, 2007
Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatmentVera Bongertz, E Priscilla Ouverney, Saada Chequer Fernandez, et al.
Memorias Do Instituto Oswaldo Cruz|May 24, 2003
Anti-human immunodeficiency virus-1 antibody titers in injection drug users compared to sexually infected individualsVera Bongertz, Elaine Priscilla Ouverney, Sylvia L M Teixeira, et al.
AIDS Research and Human Retroviruses|November 14, 2012
Short communication: neutralizing antibodies in HIV-1-infected Brazilian individualsDalziza Victalina Almeida, Mariza Gonçalvez Morgado, Fernanda Heloise Côrtes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 7, 2004
HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversitySylvia Lopes Maia Teixeira, Francisco Inácio Bastos, Paulo Roberto Telles, et al.
Journal of Medical Virology|August 22, 2009
Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1Gonzalo Bello, Carlos A Velasco-de-Castro, Vera Bongertz, et al.
Pageof 2